BCIQ Profiles

Company Profile Report

Tesla developing RNA therapeutic ‘microfactories’ for CureVac, plus CRISPR-directed RNA epigenetic modifications and Nucleix

BioCentury’s roundup of preclinical news

Tesla ‘microfactories’ for CureVac

Elon Musk tweeted on Wednesday that Tesla Grohmann Automation GmbH unit of Tesla Inc. (NASDAQ:TSLA) is building RNA “microfactories” for CureVac AG, which has an

Read the full 285 word article

How to gain access

Continue reading with a
two-week free trial.